Search AMIA.org
AMIA Urges Congressional Action to Eliminate Barriers to Patient Identification
Through the Patient ID Now coalition, AMIA along with over 150 healthcare organizations urge Congress to remove Section 510 from the FY2026 Labor-HHS Appropriations bill, which bans funding for a national unique patient identifier. This outdated provision hinders patient safety, contributes to medical errors, and causes costly inefficiencies—totaling over $6.7 […]
AMIA 2025 Annual Symposium Schedule-at-a-glance
AMIA Joins CHF Letter Urging Congress to Reject HHS Budget Cuts
AMIA joined Coalition for Health Funding’s letter, signed by over 500 health and research organizations, strongly opposing the Administration’s draft FY 2026 budget proposal for the Department of Health and Human Services (HHS), which includes a one-third cut to discretionary funding. The coalition warns such cuts would severely harm the […]
AMIA Joins Call for Continued Investment in ARPA-H
On April 23, 2025, AMIA joined over 100 organizations urging Congress to allocate at least $1.7 billion for the Advanced Research Projects Agency for Health (ARPA-H) in FY 2026, emphasizing the importance of maintaining its independence within the Department of Health and Human Services. ARPA-H, modeled after DARPA, has initiated […]
The Washington Download - Vol. 10 Issue 8

Questions for Senate HELP Committee for Potential Hearing on HHS Reorganization
AMIA raised concerns about the evidence behind the HHS reorganization decisions and questions the exclusion of the Assistant Secretary for Technology Policy/Office of the National Coordinator of Health IT (ASTP). It highlights the importance of ASTP in securing patient data and supporting clinical care. AMIA also questioned the potential move […]
Spotlight Sessions at CIC 2025
The Washington Download - Vol. 10 Issue 7

FDA Draft Guidance Document: AI-Enabled Device Software Functions
AMIA responded to the FDA's draft guidance on "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations." We commended the FDA for its comprehensive approach to ensuring the safe and effective use of AI-enabled devices in healthcare. The comment letter emphasized the importance of transparency, bias control, and […]